Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Alkermes Plc
(NQ:
ALKS
)
19.19
USD
-0.01 (-0.05%)
Official Closing Price
Updated: 6:47 PM EST, Mar 2, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Alkermes Plc
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Resources for Those Recovering From or Struggling With Alcohol Use Disorder
November 02, 2020
Tags
Mental Health
Responsible Production & Consumption
Disease Awareness
From
3BL Media: Corporate Social Responsibility, Energy and Health News
A Meaningful Difference for Cancer Patients and Loved Ones
October 30, 2020
Tags
Employee Engagement
Corporate Social Responsibility
Disease Awareness
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Reschedules Third Quarter 2020 Financial Results Conference Call to 10:30 a.m. ET
October 29, 2020
Alkermes plc (Nasdaq: ALKS) announces that the conference call to discuss the company's third quarter financial results is rescheduled due to technical difficulties impacting the conference call...
From
PR Newswire
Alkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial Expectations
October 29, 2020
- Company Reports Third Quarter Revenues of $265.0 Million, GAAP Net Loss per Share of $0.00 and Basic and Diluted Non-GAAP Earnings per Share of $0.26 -
From
PR Newswire
Lyra Therapeutics Appoints Nancy L. Snyderman To Its Board of Directors
October 28, 2020
Lyra Therapeutics Appoints Nancy L. Snyderman To Its Board of Directors
From
Business Wire News Releases
Alkermes to Host Conference Call to Discuss Third Quarter 2020 Financial Results
October 22, 2020
Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (12:00 p.m. GMT) on Thursday, Oct. 29, 2020 to discuss the company's third quarter 2020 financial...
From
PR Newswire
FDA Advisory Committee Votes in Support of ALKS 3831 for the Treatment of Schizophrenia and Bipolar I Disorder
October 09, 2020
Alkermes plc (Nasdaq: ALKS) today announced positive voting outcomes from the joint meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory...
From
PR Newswire
Trading in Alkermes Ordinary Shares Halted Today
October 09, 2020
-- FDA Advisory Committee to Review New Drug Application for ALKS 3831 for the Treatment of Adults with Schizophrenia or Bipolar I Disorder --
From
PR Newswire
Alkermes Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on ALKS 3831
October 07, 2020
Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has posted on its website briefing documents for the Oct. 9, 2020 joint meeting of the Psychopharmacologic...
From
PR Newswire
Physical Distancing During COVID-19 Doesn't Have To Mean Feeling Alone
September 29, 2020
Tags
Public Health
Improving Healthcare Access
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Recovery Month at Alkermes
September 24, 2020
Tags
Responsible Production & Consumption
Disease Awareness
Mental Health
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Shares Mental Health Resources During National Suicide Prevention Month
September 21, 2020
Tags
suicide prevention month
Social Impact & Volunteering
Alkermes
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Thinking about trading options or stock in Apple, Dave & Buster's, Alkermes, American Airlines, or Arch Resources?
September 18, 2020
InvestorsObserver issues critical PriceWatch Alerts for AAPL, PLAY, ALKS, AAL, and ARCH.
From
PR Newswire
Alkermes Presents New Clinical Data on ALKS 4230 in Mini Oral Presentation at 2020 European Society for Medical Oncology (ESMO) Virtual Congress
September 18, 2020
- Data Provide Evidence of Clinical Benefit and Tolerability of ALKS 4230 as Monotherapy in Melanoma and in Combination With Pembrolizumab in Multiple Tumor Types -
From
PR Newswire
Alkermes Presents New Psychiatry Data at Psych Congress 2020 Virtual Experience
September 15, 2020
Tags
Healthcare Innovation
Events, Media & Communications
Pharma News, Research & Solutions
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Presents New Psychiatry Data at Psych Congress 2020 Virtual Experience
September 14, 2020
-- New Outcomes Research Analyzed Patterns of Weight Gain and Treatment Interruptions Associated With the Use of Second-Generation Oral Antipsychotics in Patients With Schizophrenia or Bipolar I...
From
PR Newswire
Alkermes to Take Part in Cantor Virtual Global Healthcare Conference
September 09, 2020
Alkermes plc (Nasdaq: ALKS) announced today that that its Chief Executive Officer, Richard Pops, will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday,...
From
PR Newswire
Alkermes to Present New Data on Investigational Immuno-Oncology Candidate, ALKS 4230, at the 2020 European Society for Medical Oncology (ESMO) Virtual Congress
September 08, 2020
Company to Host Investor Webcast at 8:30 a.m. ET on Friday, Sept. 18, 2020
From
PR Newswire
International Overdose Awareness Day
August 31, 2020
Tags
Social Impact & Volunteering
Life Science
Responsible Production & Consumption
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Sunscreen Tips for Summer
August 21, 2020
Tags
Health & Healthcare
American Cancer Society
Public Health
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Virtual FDA Advisory Committee Meeting to Review New Drug Application for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder Tentatively Scheduled for Oct. 9, 2020
August 21, 2020
Alkermes plc (Nasdaq: ALKS) today announced that a joint meeting of the U.S. Food and Drug Administration's (FDA) Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management...
From
PR Newswire
Alkermes Initiates Phase 2 Study Designed to Evaluate Clinical and Immunologic Activity of ALKS 4230 on Tumor Microenvironment in Patients with Advanced Solid Tumors
August 19, 2020
Alkermes plc (Nasdaq: ALKS) today announced the initiation of ARTISTRY-3, a new phase 2 study to evaluate the clinical and immunologic effects of ALKS 4230 monotherapy on the tumor microenvironment of...
From
PR Newswire
American Journal of Psychiatry Publishes Data From Alkermes' Phase 3 ENLIGHTEN-2 Weight Study of ALKS 3831 in Patients With Schizophrenia
August 17, 2020
Alkermes plc (Nasdaq: ALKS) today announced the publication of results from the phase 3 ENLIGHTEN-2 clinical trial of ALKS 3831 (olanzapine/samidorphan) in the peer-reviewed publication, American...
From
PR Newswire
NetworkNewsBreaks – Alkermes plc (NASDAQ: ALKS) Featured in Mizuho Securities Research Report
July 30, 2020
From
InvestorBrandNetwork
Alkermes Releases Third Annual Corporate Responsibility Report
July 29, 2020
Tags
CSR Reports
Responsible Production & Consumption
Governance
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes plc Reports Second Quarter 2020 Financial Results and Issues 2020 Financial Expectations
July 29, 2020
-- Company Reports Second Quarter Revenues of $247.5 Million, GAAP Net Loss per Share of $0.19 and Diluted Non-GAAP Earnings per Share of $0.06 --
From
PR Newswire
Alkermes to Host Conference Call to Discuss Second Quarter 2020 Financial Results
July 22, 2020
Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, July 29, 2020 to discuss the company's second quarter 2020 financial...
From
PR Newswire
Alkermes: Supporting Our Patients During COVID-19
July 22, 2020
Tags
Public Health
Schizophrenia
Pharma News, Research & Solutions
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Melanoma: Risk Factors and Prevention
July 14, 2020
Tags
skin cancer
NASDAQ:ALKS
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Cancer Immunotherapy Awareness Month™ at Alkermes
June 30, 2020
Tags
Health & Healthcare
Improving Healthcare Access
SITC
From
3BL Media: Corporate Social Responsibility, Energy and Health News
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.